Featured Research

from universities, journals, and other organizations

Brain's Cannabinoid System 'Mellows' Seizures

Date:
August 17, 2006
Source:
Cell Press
Summary:
The same brain machinery that responds to the active substance in marijuana provides a central "on-demand" protection against seizures, researchers have found. They said their discoveries suggest that the "endocannabinoid" system might constitute a prime target for drugs against seizures of epilepsy and other neurodegenerative diseases.

The same brain machinery that responds to the active substance in marijuana provides a central "on-demand" protection against seizures, researchers have found. They said their discoveries suggest that the "endocannabinoid" system might constitute a prime target for drugs against seizures of epilepsy and other neurodegenerative diseases.

The findings were published by Beat Lutz and Giovanni Marsicano, of Max Planck Institute of Psychiatry and Johannes Gutenberg University in Mainz, and colleagues in the August 17, 2006, issue of the journal Neuron, published by Cell Press.

The endocannabinoid system--which includes the receptors, the natural cannabinoid compounds that trigger them, as well as the machinery for regulating the process--was already known to modulate the excitation of neuronal transmission, noted the researchers. However, it had not been established that such modulation might affect neurons in the hippocampus responsible for the "excitotoxicity" that underlies the uncontrolled activity of seizures.

Thus, Lutz, Marsicano, and his colleagues used genetic techniques to pinpoint the role of the endocannabinoid system on these neurons and on seizure activity. They used mice as their animal model and induced seizures in these mice with the chemical kainic acid (KA).

In particular, they wanted to explore the role played by the endocannabinoid system in hippocampal neurons that are responsive to the neurotransmitter glutamine. These neurons are known to play a central role in seizure activity. The endocannabinoid regulatory system is also active in another type of neuron triggered by the neurotransmitter gamma-aminobutyric acid (GABA).

Thus, the researchers conducted experiments in which they genetically knocked out the endocannabinoid receptor CB1 and analyzed the effects on seizure sensitivity. They found that, indeed, when they knocked out CB1 in glutamatergic, but not GABAergic neurons, the chemically induced seizures increased in the mice. In fact, their experiments all but ruled out the role of GABAergic neurons in the seizure-protection function, they concluded.

"Altogether, these results confirm that physiological endocannabinoid-dependent control of GABAergic transmission depends on intact CB1 signaling in GABAergic interneurons and suggest that the endocannabinoid system does not influence GABAergic transmission during the development of KA-induced seizures," they concluded. "Therefore, direct modulation of glutamatergic transmission by CB1 receptors expressed on cortical glutamatergic neurons appears to be the major mechanism of endocannabinoid-mediated protection against KA-induced seizures."

Furthermore, the researchers' experiments established that endocannabinoid receptors were also present in the same glutamatergic neurons in areas of the hippocampus known to be central to seizure generation. The researchers wrote that this finding "represents a novel step in understanding the progression of acute excitotoxic seizures and the development of epileptic states."

And significantly, when the researchers used a targeted virus to knock out the CB1 gene for the endocannabinoid receptor specifically in the glutamatergic neurons of the hippocampus, the mice also showed strong worsening of chemically induced seizures in comparison to mice still expressing CB1.

"Altogether, these observations support a hypothetical scenario in which acute KA-induced excitotoxic seizures would activate the endocannabinoid system in respect to its ability to inhibit only 'harmful' glutamatergic transmission, but not 'protective' GABAergic release," concluded Lutz, Marsicano, and colleagues.

"In conclusion, our study reveals a mechanism through which the endocannabinoid system is able to provide on-demand protection against acute behavioral seizures. CB1 expression on hippocampal glutamatergic circuits accounts for this protection and might represent a suitable target for the treatment of neurological disorders associated with excessive neuronal excitation," they wrote.

The researchers include Krisztina Monory, Federico Massa, and Beat Lutz of Johannes Gutenberg University in Mainz, Germany and Max Planck Institute of Psychiatry in Munich, Germany; Michaela Egertová and Maurice R. Elphick of Queen Mary, University of London in London, United Kingdom; Matthias Eder, Heike Blaudzun, Wolfgang Kelsch, Wolfgang Jacob, Rudolf Marsch, Barbara Wölfel, Hans-Ulrich Dodt, Walter Zieglgänsberger, and Carsten T. Wotjak of Max Planck Institute of Psychiatry in Munich, Germany; Ruth Westenbroek and Ken Mackie of University of Washington in Seattle, WA; Marc Ekker of University of Ottawa in Ottawa, Ontario, Canada; Jason Long and John L. Rubenstein of University of California, San Francisco in San Francisco, CA; Sandra Goebbels and Klaus-Armin Nave of Max Planck Institute of Experimental Medicine in Göttingen, Germany; Matthew During of University of Auckland School of Medicine in Auckland, New Zealand; Matthias Klugmann of Auckland School of Medicine in Auckland, New Zealand and University of Heidelberg in Heidelberg, Germany; Giovanni Marsicano of Johannes Gutenberg University in Mainz, Germany, Max Planck Institute of Psychiatry in Munich, Germany, and AVENIR INSERM, Institute François Magendie in Bordeaux, France.

Grant support was as follows: Marie Curie Fellowship QLG1-CT-2002-51742 (to K. Monory); CIHR MOP14460 (to M.E.); Nina Ireland, MH49428 and MH065670 (to J.R.); DA00286, DA11322, and DA15916 (to K. Mackie); BBSRC S19916 (to M.R.E.); Deutsche Forschungsgemeinschaft (DFG) LU755/1-3 and a scholarship from the Hertie Foundation (to B.L.).

Monory et al.: "The Endocannabinoid System Controls Key Epileptogenic Circuits in the Hippocampus." Publishing in Neuron 51, 455--466, August 17, 2006 DOI 10.1016/j.neuron.2006.07.006 www.neuron.org

Related Preview by Alger et al.: "Preview: Not Too Excited? Thank Your Endocannabinoids."


Story Source:

The above story is based on materials provided by Cell Press. Note: Materials may be edited for content and length.


Cite This Page:

Cell Press. "Brain's Cannabinoid System 'Mellows' Seizures." ScienceDaily. ScienceDaily, 17 August 2006. <www.sciencedaily.com/releases/2006/08/060817103710.htm>.
Cell Press. (2006, August 17). Brain's Cannabinoid System 'Mellows' Seizures. ScienceDaily. Retrieved September 2, 2014 from www.sciencedaily.com/releases/2006/08/060817103710.htm
Cell Press. "Brain's Cannabinoid System 'Mellows' Seizures." ScienceDaily. www.sciencedaily.com/releases/2006/08/060817103710.htm (accessed September 2, 2014).

Share This




More Health & Medicine News

Tuesday, September 2, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

U.N. Says Ebola Travel Restrictions Will Cause Food Shortage

U.N. Says Ebola Travel Restrictions Will Cause Food Shortage

Newsy (Sep. 2, 2014) — The U.N. says the problem is two-fold — quarantine zones and travel restrictions are limiting the movement of both people and food. Video provided by Newsy
Powered by NewsLook.com
Get on Your Bike! London Cycling Popularity Soars Despite Danger

Get on Your Bike! London Cycling Popularity Soars Despite Danger

AFP (Sep. 1, 2014) — Wedged between buses, lorries and cars, cycling in London isn't for the faint hearted. Nevertheless the number of people choosing to bike in the British capital has doubled over the past 15 years. Duration: 02:27 Video provided by AFP
Powered by NewsLook.com
Can You Train Your Brain To Eat Healthy?

Can You Train Your Brain To Eat Healthy?

Newsy (Sep. 1, 2014) — New research says if you condition yourself to eat healthy foods, eventually you'll crave them instead of junk food. Video provided by Newsy
Powered by NewsLook.com
We've Got Mites Living In Our Faces And So Do You

We've Got Mites Living In Our Faces And So Do You

Newsy (Aug. 30, 2014) — A new study suggests 100 percent of adult humans (those over 18 years of age) have Demodex mites living in their faces. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins